Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.

Carrió M, Mazuelas H, Richaud-Patin Y, Gel B, Terribas E, Rosas I, Jimenez-Delgado S, Biayna J, Vendredy L, Blanco I, Castellanos E, Lázaro C, Raya Á, Serra E.

Stem Cell Reports. 2019 Mar 5;12(3):639-641. doi: 10.1016/j.stemcr.2019.02.001. No abstract available.

2.

Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.

Carrió M, Mazuelas H, Richaud-Patin Y, Gel B, Terribas E, Rosas I, Jimenez-Delgado S, Biayna J, Vendredy L, Blanco I, Castellanos E, Lázaro C, Raya Á, Serra E.

Stem Cell Reports. 2019 Feb 12;12(2):411-426. doi: 10.1016/j.stemcr.2019.01.001. Epub 2019 Jan 31. Erratum in: Stem Cell Reports. 2019 Mar 5;12(3):639-641.

3.

Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease.

di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Muñoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A.

Stem Cell Reports. 2019 Feb 12;12(2):213-229. doi: 10.1016/j.stemcr.2018.12.011. Epub 2019 Jan 10.

4.

Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A.

Olgasi C, Talmon M, Merlin S, Cucci A, Richaud-Patin Y, Ranaldo G, Colangelo D, Di Scipio F, Berta GN, Borsotti C, Valeri F, Faraldi F, Prat M, Messina M, Schinco P, Lombardo A, Raya A, Follenzi A.

Stem Cell Reports. 2018 Dec 11;11(6):1391-1406. doi: 10.1016/j.stemcr.2018.10.012. Epub 2018 Nov 8.

5.

Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA.

Martorell L, Luce E, Vazquez JL, Richaud-Patin Y, Jimenez-Delgado S, Corrales I, Borras N, Casacuberta-Serra S, Weber A, Parra R, Altisent C, Follenzi A, Dubart-Kupperschmitt A, Raya A, Vidal F, Barquinero J.

J Thromb Haemost. 2017 Nov;15(11):2188-2197. doi: 10.1111/jth.13808. Epub 2017 Sep 25.

PMID:
28834196
6.

iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology.

Matamoros-Angles A, Gayosso LM, Richaud-Patin Y, di Domenico A, Vergara C, Hervera A, Sousa A, Fernández-Borges N, Consiglio A, Gavín R, López de Maturana R, Ferrer I, López de Munain A, Raya Á, Castilla J, Sánchez-Pernaute R, Del Río JA.

Mol Neurobiol. 2018 Apr;55(4):3033-3048. doi: 10.1007/s12035-017-0506-6. Epub 2017 May 2.

7.

Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks.

Canals I, Soriano J, Orlandi JG, Torrent R, Richaud-Patin Y, Jiménez-Delgado S, Merlin S, Follenzi A, Consiglio A, Vilageliu L, Grinberg D, Raya A.

Stem Cell Reports. 2015 Oct 13;5(4):546-57. doi: 10.1016/j.stemcr.2015.08.016. Epub 2015 Sep 24.

8.

Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.

Sánchez-Danés A, Richaud-Patin Y, Carballo-Carbajal I, Jiménez-Delgado S, Caig C, Mora S, Di Guglielmo C, Ezquerra M, Patel B, Giralt A, Canals JM, Memo M, Alberch J, López-Barneo J, Vila M, Cuervo AM, Tolosa E, Consiglio A, Raya A.

EMBO Mol Med. 2012 May;4(5):380-95. doi: 10.1002/emmm.201200215. Epub 2012 Mar 8.

9.

A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells.

Raya A, Rodríguez-Pizà I, Navarro S, Richaud-Patin Y, Guenechea G, Sánchez-Danés A, Consiglio A, Bueren J, Izpisúa Belmonte JC.

Nat Protoc. 2010 Apr;5(4):647-60. doi: 10.1038/nprot.2010.9. Epub 2010 Mar 11.

PMID:
20224565
10.

Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.

Rodríguez-Pizà I, Richaud-Patin Y, Vassena R, González F, Barrero MJ, Veiga A, Raya A, Izpisúa Belmonte JC.

Stem Cells. 2010 Jan;28(1):36-44. doi: 10.1002/stem.248.

11.

Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors.

Fragoso-Loyo H, Cabiedes J, Richaud-Patin Y, Orozco-Narváez A, Diamond B, Llorente L, Sánchez-Guerrero J.

Rheumatology (Oxford). 2009 Dec;48(12):1615-6. doi: 10.1093/rheumatology/kep297. Epub 2009 Sep 15. No abstract available.

12.

P-glycoprotein activity in renal clear cell carcinoma.

Soto-Vega E, Arroyo C, Richaud-Patin Y, García-Carrasco M, Vázquez-Lavista LG, Llorente L.

Urol Oncol. 2009 Jul-Aug;27(4):363-6. doi: 10.1016/j.urolonc.2008.01.011. Epub 2008 Apr 28.

PMID:
18440836
13.

An unusual multiplex systemic lupus erythematosus family with high prevalence of nephropathy, late-onset disease, and one member with disease-onset post-HIV therapy.

Jakez-Ocampo J, Carrillo-Maravilla E, Richaud-Patin Y, Soto-Vega E, Atisha-Fregoso Y, Llorente L.

J Clin Rheumatol. 2008 Feb;14(1):34-7. doi: 10.1097/RHU.0b013e3181639abe.

PMID:
18431097
14.

Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance.

Vargas-Rojas MI, Crispín JC, Richaud-Patin Y, Alcocer-Varela J.

Lupus. 2008 Apr;17(4):289-94. doi: 10.1177/0961203307088307.

PMID:
18413409
15.

Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.

Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J.

Arthritis Rheum. 2007 Apr;56(4):1242-50.

16.

Lupus nephritis remission, albeit with positive anti-doping test.

Jakez-Ocampo J, Richaud-Patin Y, Llorente L.

Joint Bone Spine. 2007 Jan;74(1):96-7. Epub 2006 Feb 17.

PMID:
17254825
17.

Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia.

García-Valladares I, Atisha-Fregoso Y, Richaud-Patin Y, Jakez-Ocampo J, Soto-Vega E, Elías-López D, Carrillo-Maravilla E, Cabiedes J, Ruiz-Argüelles A, Llorente L.

Lupus. 2006;15(9):600-5.

PMID:
17080916
18.

Lupus nephritis outcome with and without renal biopsy: a 5-year comparative study.

Jakez-Ocampo J, Arreola-Zavala R, Richaud-Patin Y, Romero-Díaz J, Llorente L.

J Clin Rheumatol. 2004 Dec;10(6):289-94.

PMID:
17043535
20.

The gut: beyond immunology.

Richaud-Patin Y, Soto-Vega E, Llorente L.

Reumatol Clin. 2005 Aug;1(2):121-8. doi: 10.1016/S1699-258X(05)72725-X. Epub 2008 Dec 20.

21.

Effect of rapamycin on cytokine profile in kidney transplant recipients treated with triple drug therapy.

Morales-Buenrostro LE, Llorente L, Richaud-Patin Y, de Leo C, Soto-Vega E, Díaz-Alderete A, Vázquez-Lavista LG, Coto S, Correa-Rotter R, Alberú J.

Transplant Proc. 2004 Jul-Aug;36(6):1661-3.

PMID:
15350444
22.

Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients.

Richaud-Patin Y, Vega-Boada F, Vidaller A, Llorente L.

Biomed Pharmacother. 2004 Jun;58(5):320-4.

PMID:
15194168
23.

Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.

Soto-Vega E, García-Muñoz R, Richaud-Patin Y, Zúñiga-Ramos J, Crispín JC, Díaz-Jouanen E, Flores-Suárez LF, Llorente L, Granados J.

Immunol Lett. 2004 May 15;93(2-3):211-5.

PMID:
15158619
24.

P-glycoprotein in autoimmune diseases.

Richaud-Patin Y, Soto-Vega E, Jakez-Ocampo J, Llorente L.

Autoimmun Rev. 2004 Mar;3(3):188-92. Review.

PMID:
15110230
25.

In vivo IL-10 and TGF-beta production by PBMC from long-term kidney transplant recipients with excellent graft function: a possible feedback mechanism participating in immunological stability.

Alberú J, Richaud-Patin Y, Vázquez-Lavista LG, de Leo C, Guzmán-Rodríguez H, Mancilla E, Correa-Rotter R, Chew-Wong A, Llorente L.

Clin Transplant. 2004 Apr;18(2):174-8.

PMID:
15016132
26.

Weekly leflunomide as monotherapy for recent-onset rheumatoid arthritis.

Jakez-Ocampo J, Richaud-Patin Y, Granados J, Sánchez-Guerrero J, Llorente L.

Arthritis Rheum. 2004 Feb 15;51(1):147-8. No abstract available.

27.

CD8+ chronic lymphocytic leukemia: an extensive characterization of a bizarre hybrid neoplasia.

Richaud-Patin Y, Piedras J, Carrillo-Maravilla E, López-Karpovitch X, Llorente L.

Eur J Haematol. 2003 Sep;71(3):224-30.

PMID:
12930326
28.

Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.

Richaud-Patin Y, Pérez-Romano B, Carrillo-Maravilla E, Rodriguez AB, Simon AJ, Cabiedes J, Jakez-Ocampo J, Llorente L, Ruiz-Argüelles A.

Immunol Lett. 2003 Aug 5;88(2):95-9.

PMID:
12880676
29.
30.

The role of interleukin-10 in systemic lupus erythematosus.

Llorente L, Richaud-Patin Y.

J Autoimmun. 2003 Jun;20(4):287-9. Review. No abstract available.

PMID:
12791314
31.

Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission.

Crispin JC, Alcocer-Varela J, de Pablo P, Martínez A, Richaud-Patin Y, Alarcón-Segovia D.

Lupus. 2003;12(5):386-93.

PMID:
12765302
32.

Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study.

Jakez-Ocampo J, Richaud-Patin Y, Simón JA, Llorente L.

Joint Bone Spine. 2002 May;69(3):307-11.

PMID:
12102278
33.

Systemic lupus erythematosus with thyroiditis: a therapeutic dilemma?

Jakez-Ocampo J, Richaud-Patin Y, Pérez-E B, Llorente L.

Clin Exp Rheumatol. 2002 Jan-Feb;20(1):114-5. No abstract available.

PMID:
11892696
34.

[Multidrug resistance: a century after "606"].

Llorente L, Richaud-Patin Y, Jakez-Ocampo J.

Rev Invest Clin. 2001 Sep-Oct;53(5):444-51. Spanish. No abstract available.

PMID:
11795110
35.

Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies.

Pacheco-Tena C, Alvarado De La Barrera C, López-Vidal Y, Vázquez-Mellado J, Richaud-Patin Y, Amieva RI, Llorente L, Martínez A, Zúñiga J, Cifuentes-Alvarado M, Burgos-Vargas R.

Rheumatology (Oxford). 2001 Aug;40(8):920-7.

PMID:
11511762
36.

Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE).

de la Fuente H, Richaud-Patin Y, Jakez-Ocampo J, González-Amaro R, Llorente L.

Immunol Lett. 2001 Jul 2;77(3):175-80.

PMID:
11410251
37.

Effect of cyclosporine withdrawal on IL-10 production in kidney transplant recipients.

Alberú J, Richaud-Patin Y, Mancilla E, Díliz H, Correa-Rotter R, Chew-Wong A, Uribe N, de Leo C, Llorente L.

Transplant Proc. 2001 Feb-Mar;33(1-2):2024-7. No abstract available.

PMID:
11267610
38.

Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology.

Llorente L, De La Fuente H, Richaud-Patin Y, Alvarado-De La Barrera C, Diaz-Borjón A, López-Ponce A, Lerman-Garber I, Jakez-Ocampo J.

Immunol Lett. 2000 Nov 1;74(3):239-44.

PMID:
11064109
39.

High prevalence of protein-dependent and protein-independent antiphospholipid and other autoantibodies in healthy elders.

Richaud-Patin Y, Cabiedes J, Jakez-Ocampo J, Vidaller A, Llorente L.

Thromb Res. 2000 Jul 15;99(2):129-33. No abstract available.

PMID:
10946086
40.

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.

Llorente L, Richaud-Patin Y, García-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcón-Segovia D, Wijdenes J, Galanaud P, Emilie D.

Arthritis Rheum. 2000 Aug;43(8):1790-800.

41.

Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.

Diaz-Borjon A, Richaud-Patin Y, Alvarado de la Barrera C, Jakez-Ocampo J, Ruiz-Argüelles A, Llorente L.

Joint Bone Spine. 2000 Jan;67(1):40-8.

PMID:
10773967
42.

Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome.

Llorente L, Richaud-Patin Y, Díaz-Borjón A, Alvarado de la Barrera C, Jakez-Ocampo J, de la Fuente H, Gonzalez-Amaro R, Diaz-Jouanen E.

Joint Bone Spine. 2000 Jan;67(1):30-9.

PMID:
10773966
43.

Increased collagenase and dipeptidyl peptidase I activity in leucocytes from healthy elderly people.

Llorente L, Richaud-Patin Y, Díaz-Borjón A, Jakez-Ocampo J, Alvarado-De La Barrera C.

Clin Exp Immunol. 1999 Jun;116(3):425-9.

44.

Possible role of interleukin-10 in autoantibody production and in the fate of human cord blood CD5+ B lymphocytes.

Villaseñor-Bustamante S, Alvarado-De La Barrera C, Richaud-Patin Y, Martínez-Ayala H, Llorente L.

Scand J Immunol. 1999 Jun;49(6):629-32.

45.

Differential oncogene and TNF-alpha mRNA expression in bone marrow cells from systemic lupus erythematosus patients.

Alvarado-de la Barrera C, Alcocer-Varela J, Richaud-Patin Y, Alarcón-Segovia D, Llorente L.

Scand J Immunol. 1998 Nov;48(5):551-6.

46.

Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.

González-Amaro R, Portales-Pérez D, Baranda L, Abud-Mendoza C, Llorente L, Richaud-Patin Y, Alcocer-Varela J, Alarcón-Segovia D.

J Autoimmun. 1998 Oct;11(5):395-402.

PMID:
9802922
47.

[Four cases of parathyroid cancer].

Chew-Wong A, Herrera MF, Jiménez ED, Gamboa-Domínguez A, Richaud-Patin Y, Bezaury P, Reza-A A, Correa-Rotter R, Rull JA.

Rev Invest Clin. 1998 May-Jun;50(3):239-44. Spanish.

PMID:
9763890
48.

Spontaneous cytokine gene expression by cultured skin fibroblasts of systemic sclerosis. Correlation with collagen synthesis.

Zurita-Salinas CS, Richaud-Patin Y, Krötzsch-Gómez E, Llorente L, Alcocer-Varela J, Díaz-de-León L, Palacios-Boix A.

Rev Invest Clin. 1998 Mar-Apr;50(2):97-104.

PMID:
9658927
49.

Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus.

Llorente L, Richaud-Patin Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, Alcocer-Varela J, Granados J, Bahena S, Galanaud P, Emilie D.

Arthritis Rheum. 1997 Aug;40(8):1429-35.

PMID:
9259422
50.

Profile of cytokine mRNA expression in spontaneous and UV-induced skin lesions from actinic prurigo patients.

Santos-Martínez L, Llorente L, Baranda L, Richaud-Patin Y, Torres-Alvarez B, Moncada B, González-Amaro R.

Exp Dermatol. 1997 Apr;6(2):91-7.

PMID:
9209891

Supplemental Content

Loading ...
Support Center